RG
BMY icon

Rikoon Group’s Bristol-Myers Squibb BMY Stock Holding History

Rikoon Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$2.99M Buy
47,050
+47
+0.1% +$2.92K 0.8% 29
2020
Q4 		$2.94M Buy
47,003
+1
+0% +$61 0.82% 30
2020
Q3 		$2.83M Sell
47,002
-231
-0.5% -$13.9K 0.88% 28
2020
Q2 		$2.78M Sell
47,233
-947
-2% -$56.6K 0.93% 27
2020
Q1 		$2.69M Buy
48,180
+356
+0.7% +$21.8K 1.11% 22
2019
Q4 		$3.07M Buy
47,824
+2,186
+5% +$125K 1.06% 25
2019
Q3 		$2.31M Buy
45,638
+400
+0.9% +$18.8K 0.86% 33
2019
Q2 		$2.05M Sell
45,238
-150
-0.3% -$6.99K 0.76% 35
2019
Q1 		$2.17M Sell
45,388
-700
-2% -$34.9K 0.81% 31
2018
Q4 		$2.4M Hold
46,088
– – 0.99% 24
2018
Q3 		$2.86M Sell
46,088
-104
-0.2% -$6.17K 1.01% 23
2018
Q2 		$2.56M Buy
46,192
+317
+0.7% +$17.1K 0.98% 27
2018
Q1 		$2.84M Buy
45,875
+4,380
+11% +$282K 1.15% 24
2017
Q4 		$2.54M Buy
41,495
+454
+1% +$28.4K 1.05% 27
2017
Q3 		$2.62M Buy
41,041
+431
+1% +$25.2K 1.13% 25
2017
Q2 		$2.26M Buy
40,610
+2
+0% +$109 1% 29
2017
Q1 		$2.29M Sell
40,608
-157
-0.4% -$8.61K 1.01% 28
2016
Q4 		$2.1M Buy
40,765
+33,738
+480% +$1.84M 0.93% 34
2016
Q3 		$378K Buy
+7,027
New +$451K 0.3% 88

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rikoon Group's BMY Position: Q1 2021 in Review

Rikoon Group increased its Bristol-Myers Squibb (BMY) stake by 0.1% in Q1 2021, buying an estimated $2.92K and bringing the position to 47,050 shares worth $2.99M. The position accounts for 0.8% of the portfolio, ranked #29.

Rikoon Group first reported a position in BMY in Q3 2016 and has held it in 19 quarters since. The position peaked at $3.07M in Q4 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Rikoon Group held 47,050 shares of Bristol-Myers Squibb worth $2.99M as of Q1 2021.
  • Rikoon Group bought 47 Bristol-Myers Squibb shares in Q1 2021, an estimated $2.92K.
  • Bristol-Myers Squibb made up 0.8% of Rikoon Group's portfolio in Q1 2021, its #29 holding.
  • Rikoon Group first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 19 quarters since.
  • Rikoon Group's Bristol-Myers Squibb position peaked at $3.07M in Q4 2019.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.